rhomboid
The Drosophila Malpighian tubules (MTs), form a simple excretory epithelium comparable in function to kidneys in vertebrates. MTs function as the insect kidney both in the larva and the adult. They consist of two pairs of blind ending tubes that are composed of a single cell-layered epithelium made up of a tightly controlled number of cells. The tubules float in the hemolymph from where they take up nitrogenous waste that is excreted as uric acid. During embryogenesis, MTs evert as four protuberances from the hindgut primordium, the proctodeum. The everting tubules grow by cell proliferation, which takes place in a few cells along the tubules and extensively in a distal proliferation domain located in the tip region of the tubules. Cell ablation experiments and studies on the pattern of cell division have shown that a single large cell at the distal end of each tubule, termed the tip cell, is decisive for controlling the proliferation of its neighboring cells. The tip cell that differentiates into a cell with neuronal characteristics during later stages of development arises by division of a tip mother cell that is selected in the tubule primordium by lateral inhibition involving the Notch signaling pathway and the transcription factor Krüppel (Kr). It has been suggested that the tip cell sends a mitogenic signal to adjacent cells in the distal proliferation zone. It has remained elusive, however, what the signal is or what its target molecules in the signal-receiving cells could be and how cell proliferation during MT morphogenesis is regulated. Seven-up is shown to be a key component that becomes induced in response to mitogenic EGF receptor signaling activity emanating from the tip cell. Seven-up (Svp) in turn is capable of regulating the transcription of cell cycle regulators (Kerber, 1998).
To identify the nature of the mitogenic tip cell signal a screen was carried out for genes specifically active in the tip
cells. The genes rhomboid (rho) and Star (S), which encode transmembrane proteins
involved in epidermal growth factor receptor (EGFR) signaling, are
expressed in the tip cells and both are required for MT growth. When the tubules start to evert,
rho and S are expressed in the tip mother cell; subsequently rho is strongly expressed in the tip cell and S in the tip cell and its former sister cell. An analysis of the MTs
in the corresponding amorphic mutants reveals a strong decrease of cells in rho mutants and a
weaker decrease in S mutants. In a rho;S double mutant, the tubules are barely detectable, indicating that rho and S activities are essential (albeit redundant) components controlling MT
growth. The tubule phenotype of rho;S double mutants is very similar to that of EGFR mutants,
which also show a drastic decrease in the tubule cell number. As in svp mutants, the allocation and the differentiation of the tip cells are normal in the receptor
mutants, indicating that receptor activity is not required for tip cell determination and
differentiation. The reduction of the tubule cell number in EGFR mutants is due to a failure of proper cell divisions. No BrdU incorporation occurs in EGFR mutants in the outbudding tubules at the time when cells divide in wild-type embryos. However, BrdU incorporation occurs again much later during the
endomitotic cycles, indicating that in EGFR muants, a specific defect in DNA replication
exists in cells that would normally divide (Kerber, 1998).
Rho and S process a membrane-bound form of the activating ligand of the receptor, the TGFalpha-like Spi protein, to generate the secreted form of Spi (sSpi). sSpi is then proposed to
diffuse to neighboring cells, bind to the receptor, and activate target genes via the Ras/Raf signaling
cassette; these include the primary target gene pointedP1 (pntP1), encoding an ETS domain
transcription factor, and the secondary target gene argos (aos), encoding a
negatively acting ligand of the receptor. These
downstream components of the pathway are also active during tubule development. pntP1 and aos are expressed during stage 10 in six to eight cells on one side of the MTs overlapping the rho and S expression domains and later, weakly in several cells in the tip region. In amorphic aos mutants a slightly larger number of tubule cells are observed, whereas amorphic pnt mutants show a decrease of tubule cells. These results indicate that for controlling cell proliferation and cell
determination, the same key components of the EGFR cascade are required (Kerber, 1998).
These findings suggest that the EGFR pathway provides the mitogenic tip cell signal that activates svp expression and regulates cell division. To test this hypothesis, svp expression was analyzed in EGFR mutants and ectopic expression studies were performed with various members of the pathway using the UAS-Gal4 system. svp is absent in mutants for the Egfr. It is still expressed, however, in amorphic pnt mutants, suggesting that Svp is a
transcriptional regulator that is likely to be activated in parallel to the primary transcription factor PntP1
in the signaling cascade. If sSpi activity is provided ectopically in all of the tubule cells, the svp expression domain becomes dramatically expanded and an increase of the tubule cell number is observed.
Similar, although slightly weaker effects on svp transcription and the number of tubule cells could be
observed upon ubiquitous expression of other components of the EGFR pathway, like Rho, activated
Ras, or Raf. Conversely, when a dominant-negative Ras allele is ectopically expressed
in all of the tubule cells, svp transcription became strongly reduced. Ectopic
expression of svp in an Egfr mutant background restores the tubule cell number to a considerable extent. These results provide strong evidence that svp is a downstream target gene of
EGFR signaling in the tubules (Kerber, 1998).
Rhomboid and the ventral cuticle The spitz-group mutants (spitz, rhomboid, and pointed) are embryonic lethal and have similar cuticle phenotypes; they are shorter than wild type and have deletions of ventral cuticle. vein mutant are shorter and the Keilin's organs and ventral black dots are closer together than in wild-type. Ventral cuticle is deleted between Keilin's organs. The deletions occur in a similar region in spitz-group mutants; spitz and rhomboid have a larger portion of ventral cuticle deleted than vein mutants, but pointed embryos have similar deletions. In vein
mutants sensory hairs surrounding the pit structure of Keilin's organs are missing. Unlike the spi-group genes, vein is not critical for embryonic survival and head skeleton and sense organs are normal. Most vein mutants die either as embryos or as larvae, but a small number do pupariate. Individuals that survive to pupariate secrete a pupal case with pattern abnormalities (Schnepp, 1996).
Rhomboid and chordotonal development The selection of Drosophila sense organ
precursors (SOPs) for sensory bristles is a progressive
process: each neural equivalence group is transiently
defined by the expression of proneural genes (proneural
cluster), and neural fate is refined to single cells by Notch-Delta
lateral inhibitory signalling between the cells. Unlike
sensory bristles, SOPs of chordotonal (stretch receptor)
sense organs are tightly clustered. It has been shown that for
one large adult chordotonal SOP array (the adult femoral chordotonal sense organ), clustering results
from the progressive accumulation of a large number of
SOPs from a persistent proneural cluster. This is achieved
by a novel interplay of inductive epidermal growth factor-
receptor (EGFR) and competitive Notch signals. EGFR
acts in opposition to Notch signaling in two ways: it
promotes continuous SOP recruitment despite lateral
inhibition, and it attenuates the effect of lateral inhibition
on the proneural cluster equivalence group, thus
maintaining the persistent proneural cluster. SOP
recruitment is reiterative because the inductive signal
comes from previously recruited SOPs (zur Lage, 1999).
The adult femoral chordotonal sense organ arises from a group of some 70-80 SOPs. A developmental
analysis of Ato expression has revealed that these SOPs accumulate
over an extended period of time in the dorsal region of each leg
imaginal disc during the third larval instar and early pupa. The continued expression of Ato implies a sustained
requirement for proneural function throughout the process of
SOP accumulation. Unusually, Ato is persistently expressed in
a group of ectodermal cells identified as the proneural cluster (PNC). From this PNC, cells are funnelled inward into a cavity
formed by the folding of the disc. This invagination later
becomes visible as a distinctive 2-cell wide intrusion, which is
referred to as the 'stalk'. Cells at the deepest end of the stalk
undergo shape changes to form an amorphous inner SOP mass.
Invaginating cells are characterised by upregulation of Ato
expression, a characteristic of SOP commitment. Surprisingly, SOP markers (Ase protein and the A101
enhancer trap line) are not expressed in all
the stalk SOPs. Instead, these markers are only apparent in older
cells, particularly at the time when they become part of the inner
mass (which is therefore referred to as mature SOPs).
Despite this, entry into the stalk seems to mark SOP
commitment, since both the stalk and the mature SOPs are
absent in discs from ato mutant larvae. This
apparent intermediate stage may not have a counterpart in
external sense organ precursor formation, although there is
some evidence for multiple steps between the uncommitted cell
and the SOP (the so-called pre-sensory
mother cell state).
Initially, Ato remains activated in all invaginated SOPs. This
extended period of proneural gene expression is unusual since
AS-C proneural expression is typically switched off in SOPs
shortly after commitment. Later, at
approximately 6 hours before puparium formation (BPF), Ato expression is switched off
synchronously in the mature SOPs, although expression
remains in the stalk SOPs and the PNC. At this
point there is very little overlap between Ato and Ase or A101 (zur Lage, 1999).
The process of chordotonal SOP formation described above is
at odds in several respects with the well-known paradigm of
SOP selection for sensory bristles. In the latter, the solitary
SOP expresses Delta, which triggers expression in the PNC of
genes of the E(spl)-C, thereby
preventing further SOP commitment and forcing loss of AS-C
expression and neural competence. In the case of the femoral
chordotonal organ, newly committed cells from the PNC are
in contact with previously committed SOPs in the stalk, but are
apparently not receiving (or not responding to) lateral
inhibition signals from these to prevent their commitment.
Likewise, the presence of committed SOPs does not switch off
ato expression in the PNC. Nevertheless, components of the N-Dl
pathway are expressed in patterns consistent with lateral
inhibition. The newly formed SOPs express Dl, suggesting that
they send inhibitory signals, while the PNC expresses
mgamma, a member of the E(spl)-C, suggesting that these
cells are responding to the Notch-Delta signal.
Indeed, mgamma is coexpressed with ato in the PNC throughout the
development of the SOP cluster. Chordotonal SOP formation is
shown to be sensitive to N inhibitory signaling.
Strong activation of N signaling or its effectors can
inhibit chordotonal SOP formation.
Thus, N signaling has an important role to play: it acts to limit
the process of SOP selection from the PNC. Some mechanism,
however, must prevent N signaling from completely inhibiting
multiple SOP formation (zur Lage, 1999).
The progressive accumulation of chordotonal SOPs suggests
that a recruitment mechanism could explain the clustering of
SOPs. The Drosophila Egfr signaling pathway is involved
in a number of recruitment processes in development, and a role for Egfr signaling has been demonstrated in the
induction of embryonic chordotonal precursors (zur Lage,
1997). Although there appear to be significant differences in
the process of SOP formation in imaginal discs, as compared with
the embryo, it was asked whether Egfr signaling is also
involved in forming the femoral chordotonal cluster. To address
this question, the pathway was conditionally disrupted by
expressing a dominant negative form of Egfr protein. Expression of UAS-Egfr
DN results in a dramatic loss of chordotonal SOPs in
late third instar imaginal leg discs (as judged by Ase protein
expression or the A101 enhancer trap line). This demonstrates that Egfr signaling is
required for the process of femoral chordotonal SOP
formation. In contrast, the appearance of bristle SOPs is
unaffected, arguing against the possibility of a nonspecific
effect on SOPs in general (zur Lage, 1999).
To determine whether Egfr signaling controls SOP
number, expression of components of the Egfr
pathway that determine the level of signaling was forced, thus resulting
in hyperactivation of the pathway. pointed (pnt) is an effector gene that encodes a transcription
factor and is activated in cells responding to
Egfr signaling. Both rho and pnt
are expressed during chordotonal SOP formation. Indeed, forced expression of rho or pnt increases chordotonal SOP formation. Egfr could promote SOP formation by stimulating the
commitment of PNC cells or by stimulating proliferation of
SOPs. Both functions would be consistent with known Egfr
roles, but
the current investigations favour the former. Analysis of Ato
expression in leg discs in which rho has been misexpressed
reveals a large invagination of cells and a smaller PNC. Shrinking of the PNC was confirmed by the reduced
extent of mgamma expression. These observations are
consistent with an increased rate of SOP commitment upon
Egfr hyperactivation. Moreover, this effect is reminiscent of
the effect of N loss of function on Ato expression, suggesting
that Egfr signaling supplies the mechanism that interferes
with lateral inhibition of SOP commitment (zur Lage, 1999).
Although it seems that cells of the PNC and stalk are
held in a state of mitotic quiescence throughout the time that
SOP fate decisions are being made, BrdU is
incorporated in the older (mature) SOPs. The experiments so far have indicated that Egfr signaling
affects SOP commitment from the PNC. To determine more
precisely the spatial patterning of Egfr activity required for
SOP clustering and N antagonism, the
expression patterns of key components of the pathway were characterized.
Localized expression of rho appears to play a central role in
spatial restriction of Egfr activity in cases where Spi is the
ligand; in these
cases it appears to mark the cells that are a source of signaling.
During development of the femoral chordotonal organ, rho is
expressed in a very restricted pattern: RHO mRNA is only
detected in the SOPs, becoming confined in the late third instar
larva to the youngest SOPs at the top of the stalk.
To identify the cells responding to rho-effected signaling,
an antibody that detects the dual-phosphorylated
(activated) form of the ERK MAP kinase (dp-ERK) was used. In leg imaginal discs, dp-ERK is detected in a
confined area corresponding to the uppermost (youngest) stalk
SOPs. Thus, like rho, dp-ERK is expressed in the newly
formed stalk SOPs. Double labelling for RHO RNA and dp-ERK
confirms this, but also suggests that the overlap in
expression is not complete: dp-ERK is detected above the
uppermost rho-expressing cells of the stalk, probably in one or
a few cells of the proneural cluster as they funnel into the stalk.
This suggests that Egfr promotes SOP commitment as a
consequence of direct signaling from previous SOPs to
overlying PNC cells. Since rho expression is itself activated
upon SOP commitment, this process occurs cyclically: the
newly recruited SOPs are in turn able to signal to further
overlying PNC cells. That is, recruitment is reiterative.
Egfr signaling via Spitz has been shown to help to maintain neural competence by
attenuation of Notch directed lateral inhibition. The opposing forces of Notch and Egfr signaling are thought to be played out through direct Notch and Egfr signaling between the epidermal proneural cells, which bear Notch, and the SOP, which sends inhibitory signals through the Delta ligand, and stimulatory signals through the Spitz ligand (zur Lage, 1999).
Reiterative recruitment alone cannot entirely explain the
accumulation of SOPs. Such an accumulation also relies on the persistence of the
competent pool of PNC cells from which SOPs can be
recruited. For AS-C PNCs, this does not occur, because the
mutual inhibition required for continued competence is
unstable and resolves quickly to a state of lateral inhibition
once the SOP emerges from the PNC.
This results in rapid shutdown of AS-C expression and hence
competence within the PNC. It is possible
that the members of E(spl)-C that are expressed in the PNC
(notably mgamma and mdelta) are less aggressive inhibitors of proneural
gene expression than the E(spl)-C members expressed in AS-C
PNCs (m5 and m8). The results obtained in the femoral SOP suggest, however, that
Egfr has a role to play in maintaining the PNC by partially
attenuating lateral inhibition on a PNC-wide scale. Thus, the
PNC is not completely shut off by inhibition from SOPs, but
instead kept in check, allowing continued mutual inhibition and
maintenance of competence but not allowing general SOP
commitment. Since neither rho nor dp-ERK are detected in the
PNC as a whole, this function of Egfr could be indirect and
achieved through partial attenuation of Dl signaling from the
stalk SOPs themselves. The trans- or auto-activation of EGFR
signaling between the stalk SOPs (as suggested by the co-expression
of dp-ERK and rho) might be an indicator
of this function. It is also possible, however, that Egfr
signaling is direct and that the dp-ERK antibody is not
sensitive enough to detect expression in the PNC cells (zur Lage, 1999).
Rhomboid and oocyte development Intercellular signaling through the EGF receptor (EGFR) patterns the Drosophila egg. The TGF alpha-like ligand Gurken signals from the oocyte to the
receptor in the overlying somatic follicle cells. In the dorsal follicle cells, this initial paracrine signaling event triggers an autocrine amplification
by two other EGFR ligands: Spitz and Vein. Spitz becomes an effective ligand only in the presence of the multitransmembrane domain protein Rhomboid.
Consequent high-level EGFR activation leads to localized expression of the diffusible inhibitor Argos, which alters the profile of signaling. This sequential
activation, amplification, and local inhibition of the EGFR forms an autoregulatory cascade that leads to the splitting in two of an initial single peak of signaling, thereby patterning the egg (Wasserman, 1998).
In other tissues Rhomboid appears to activate Spitz/Egfr signaling, leading to the suspicion that Rhomboid might mediate autocrine Spitz
signaling in the follicle cells. Consistent with this idea, the phenotype caused by loss of Spitz from the
follicle cells is similar to that caused by loss of Rhomboid. Expression of antisense rhomboid causes
loss of dorsal tissue and fusion of the appendages in eggs from heat-shocked females expressing
HS-as-rho. Unmarked follicle cell clones
of a rhomboid null mutation also give fused appendage phenotypes; as with spitz clones, these range
from mild to severe fusions. Like Spitz and the Egfr, Rhomboid is not needed in the
oocyte, implying that it,
too, is only required in the follicle cells (Wasserman, 1998).
In the absence of Egfr signaling,
rhomboid expression is lost and, conversely, it is ectopically expressed in fs(1)K10 egg chambers. These expression profiles of spitz and rhomboid are consistent
with Gurken signaling from the oocyte activating the expression of rhomboid in the follicle cells. This
may in turn allow Spitz to become an autocrine ligand in the follicle cells and thus establish an autocrine
amplification of the initial paracrine signal. The expression of the neuregulin-like Egfr ligand vein was also examined. It is also expressed in two stripes of follicle cells at stage 10b. Interestingly, vein
expression is dependent on Egfr signaling: it is ectopically expressed in fs(1)K10 eggs
and absent from gurken null eggs, establishing another potentially important feedback
mechanism. This suggests that the autocrine amplification of Egfr signaling also involves Vein,
although in this case the feedback occurs by direct transcriptional activation of the ligand (Wasserman, 1998). vein
expression has also been found to be dependent on Egfr signaling during embryogenesis (T. Volk,
personal communication to Wasserman, 1998).
The expression of the secreted Egfr inhibitor, Argos, is dependent on Egfr signaling in many tissues. Consistent with this, argos is expressed in the dorsal-anterior follicle
cells at the time when Egfr signaling occurs.
At stage 11 the RNA is detectable in a single, T-shaped group of cells centered on the dorsal midline,
and by stage 13, argos, like rhomboid and vein, is found in two groups of cells: one on either side of the
midline. As elsewhere, argos expression is dependent on Egfr activation: in gurken mutant egg
chambers it is lost, and it is ectopically expressed in fs(1)K10 egg chambers.
Is argos expression dependent on Spitz amplification of Egfr signaling? An examination was performed to see if Spitz contributes to a signaling threshold required to induce argos expression. argos
expression is normal in eggs from mothers with reduced Ras1, but
when Spitz is halved, dorsal-anterior argos expression is abolished in
most egg chambers. Therefore, there is indeed a threshold of Egfr
signaling required to switch on argos, and both Gurken and Spitz participate in reaching this threshold (Wasserman, 1998).
The initial expression of argos at the dorsal midline led to the speculation that it might cause a reduction
of Egfr signaling near the midline, thereby splitting the single signaling peak in two. The resulting
twin peaks of Egfr activation would then specify the location of the dorsal appendages.
A prediction of this model is that loss of Argos should remove inhibition of the Egfr at the midline and
produce a single peak of signaling, leading to the formation of a fused appendage phenotype. The eggs
from females with hypomorphic argos mutations were examined.
A significant proportion of these eggs have a partially or, in the most severe cases,
fully fused phenotype. The same fused appendage phenotype is observed in follicle cell clones of an
argos null mutation. These data imply that there is a requirement for Argos in
eggshell patterning and that, as with Spitz, Rhomboid, and the Egfr, this requirement is confined to the
follicle cells (Wasserman, 1998).
It is proposed that Argos modifies the initial Egfr activation profile in the follicle cells, producing twin
peaks of activity displaced from the midline. These specify the position of the dorsal
appendages. Direct evidence for a transition from one to two peaks of signaling was obtained with an
antibody that recognises only the activated, diphosphorylated form of MAP kinase, a key member of
the signal transduction pathway downstream of the receptor. At stages 9-10, there is a single domain of
activated MAP kinase in the follicle cells, centered on the dorsal midline.
By stage 11, two domains, are observed: one on each side of the dorsal midline. From their position, these
cells correspond to the cells that will form the dorsal appendages. In Egfr hypomorphs, which have a
fused appendage phenotype, the single peak of activated MAP kinase does not split
in two. These results clearly demonstrate that Egfr signaling does indeed evolve from a
single peak into twin peaks of activation. This is supported by examining the expression pattern of known Egfr target genes in the follicle cells. By stage 11 these targets (pointed, rhomboid, argos, vein, and Broad) are expressed in two dorsal anterior domains, one on each side of the midline. This is taken as additional evidence for twin peaks of Egfr activation. Earlier, pointed, rhomboid, and argos are all also detectable in a single peak at the dorsal midline (Wasserman, 1998).
Egfr signaling specifies the dorsoventral axis and patterns the eggshell. It is suggested that these
two functions are controlled by temporally separate phases of Egfr activation. When amplification
and splitting of Egfr signaling do not occur, eggs have only a single, fused appendage. Surprisingly,
larvae emerge from these eggs at the frequency predicted by Mendelian principles, and those that
emerge have no apparent dorsoventral defects. When follicle cell clones of a spitz null are induced, the hatching rate of eggs with fused appendages os 82% of the predicted number. Similarly, all of the predicted number of eggs with a single fused appendage hatch from mutant females. The same is true of
eggs with fused appendages caused by follicle cell clones of argos null mutations.
Therefore, disruption of the amplifying and splitting process does not perturb dorsoventral axis
specification, implying that the initial Gurken signal to the Egfr is sufficient to specify the axis. The subsequent cascade of amplification and splitting then patterns the eggshell (Wasserman, 1998).
Rhomboid and tracheal development The Drosophila tracheal system is a network
of epithelial tubes that arises from the tracheal placodes,
lateral clusters of ectodermal cells in ten embryonic segments.
The cells of each cluster invaginate and subsequent
formation of the tracheal tree occurs by cell migration
and fusion of tracheal branches, without cell division.
The combined action of the Decapentaplegic
(Dpp), Epidermal growth factor (EGF) and breathless/
branchless pathways are thought to be responsible
for the pattern of tracheal branches. It is asked how these
transduction pathways regulate cell migration and
the consequences on cell behaviour of the Dpp and
EGF pathways is examined. rhomboid (rho) mutant embryos
display defects not only in tracheal cell migration
but also in tracheal cell invagination unveiling a new role
for EGF signaling in the formation of the tracheal
system. These results indicate that the transduction pathways
that control tracheal cell migration are active in different
steps of tracheal formation, beginning at invagination (Llimargas, 1999).
Defects in tracheal migration are associated
with defects in invagination in rho and vvl mutant embryos,
but not in bnl and btl mutant embryos. This is
consistent with the observation that EGF-dependent activation
of MAP kinase (ERK) in the tracheal placode precedes
ERK activation by the Bnl/Btl pathway. Thus the tracheal phenotype of mutations in
the EGF pathway, which has been shown to result from
impaired activity of the pathway in the trachea, is likely to originate before the onset of migration. It has been proposed that the EGF pathway
might be required for tracheal cells in specific branches
to follow the leading cell. Tracheal migration defects of rho
mutant embryos are due, at least in part, to the failure of
some tracheal cells to invaginate (Llimargas, 1999).
Invagination of the tracheal pits is dependent on trh. This process associates with an accumulation
of actin in the cell surfaces facing the invagination and
both actin accumulation and invagination are dependent
on trh activity. Thus, the role of trh as an inducer of
tubulogenesis could stem, at least in part, from its potential
to reorganize the actin cytoskeleton. These results also indicate
that induction of tracheal invagination by trh involves
making cells competent to EGF signaling by regulating rho expression. However, there must be other targets of trh because tracheal invagination is only partially affected in rho mutant embryos. Interestingly, an interaction
between EGF signaling and trh also occurs in salivary
duct determination, suggesting
that the coordinated activity of trh and the EGF pathway
could be part of a more general mechanism for cell invagination
and tubulogenesis (Llimargas, 1999).
How, then, can EGF signaling influence cell migration?
In addressing this issue, it has to be noted that
while EGF-dependent activation of ERK in the tracheal
placodes is abolished in rho mutant embryos, tracheal invagination is only partially affected. One possibility is that EGF signaling is specifically
required for the invagination of only a subset of the tracheal
cells; this would reveal a regional subdivision
among the cells in the tracheal placode. Accordingly, the cells invaginating in rho mutant embryos would be the Dpp-induced cells, where the EGF
pathway is never activated. An alternative possibility is
that the tracheal defects in rho mutant embryos could be
due to a general decrease in the efficiency of cell invagination
that would result in fewer cells invaginating. In
that case, the branching defects in rho mutant embryos
could be attributed to a change in the topological distribution
of the tracheal cells that would alter their ability
to receive a particular signal. For instance, as fewer cells
invaginate in rho mutant embryos, almost all of them
could be reached by the Dpp signal expressed in the dorsal
and ventral side of the invaginating tracheal placode. This would explain why in rho mutant embryos the Dpp-induced branches are usually
formed and the dorsal trunk (that is formed by cells
where the Dpp pathway is not active) is completely or
partially missing. This interpretation could also account
for the observation that the rho tracheal phenotype is
more variable and less specific than the tkv phenotype (Llimargas, 1999).
These observations also illustrate the role of vvl in tracheal
formation. Since btl expression is normally initiated
in vvl mutants, early but not sustained
activity of the Btl pathway could cause the tracheal
phenotype in vvl mutant embryos. Since vvl is also required
for the tracheal expression of tkv and rho, failure to activate the Dpp and EGF pathways could also be the source of the cell
shape phenotypes in vvl mutant embryos. This latter possibility
is substantiated by the observation that vvl and
rho mutant embryos show abnormalities in tracheal invagination that are not present in btl mutant embryos.
Finally, the tkv;rho double mutant tracheal phenotype is
very similar to the vvl phenotype (Llimargas, 1999).
Multiple signaling pathways interact to determine the
formation of the different tracheal branches. However,
even though they all affect the directed migration of the
tracheal cells, they are active in different
steps in the morphogenesis of the tracheal tree. In particular,
the results show that while the Bnl/Btl pathway is
specifically required for migration, EGF signaling is active
in tracheal cell invagination. These observations also
indicate that the accurate invagination of the tracheal
cells inside the embryo is an important factor in order to
follow a particular direction of migration. In particular,
different levels of invagination could predetermine
whether cells would migrate in one or the other direction. In
this regard, it is worth noting that while in rho mutant
embryos some cells remain at the embryonic surface and
do not invaginate, in tkv mutant embryos some cells remain
in an intermediate position, indicating that they are
able to invaginate but do not reach their final location.
Altogether, these observations suggest that the precise
topology of the invaginating cells controlled by EGF and
Dpp signaling could be determining how the tracheal
cells will respond to guiding cues, such as Bnl (Llimargas, 1999).
Arthropods and higher vertebrates both possess appendages, but these are morphologically distinct and the molecular mechanisms regulating patterning along their proximodistal axis (base to tip) are thought to be quite different. In Drosophila, gene expression along this axis is thought to be controlled primarily by a combination of transforming growth factor-ß and Wnt signalling from sources of ligands, Decapentaplegic (Dpp) and Wingless (Wg), in dorsal and ventral stripes, respectively. In vertebrates, however, proximodistal patterning is regulated by receptor tyrosine kinase (RTK) activity from a source of ligands, fibroblast growth factors (FGFs), at the tip of the limb bud. This study revises understanding of limb development in flies and shows that the distal region is actually patterned by a distal-to-proximal gradient of RTK activity, established by a source of epidermal growth factor (EGF)-related ligands at the presumptive tip. This similarity between proximodistal patterning in vertebrates and flies supports previous suggestions of an evolutionary relationship between appendages/body-wall outgrowths in animals (Campbell, 2002).
A distal-to-proximal gradient of EGFR activity predicts a source of ligand(s) at the presumptive tip. Potential ligands are the TGF-alpha family members Spitz and Keren, and the neuregulin, Vn; the former require activation by the membrane protein Rhomboid (Rho), or the homolog Roughoid (Ru). Both vn and rho are expressed in the center of the leg disc in early third instars. Genetic studies show that they are redundant so that loss of either gene alone has no effect on tarsus development, but loss of both together along with ru, which shows partial redundancy with rho even though no expression can be detected, has marked effects on leg patterning and growth. Large ru rho vn triple mutant clones can result in truncations of the tarsus, although these are never as extreme as in Egfrts mutants, possibly because of the difficulty of removing all ligand-expressing cells at the center of early leg discs using this technique, or because the ru mutant used is not null. Wild-type tissue located at the tip of adult legs always correlates with rescue of tarsal development. In addition, misexpression of a secreted form of Spitz results in non-autonomous activation of al. Verification of high levels of EGFR signalling in the distal leg is revealed by expression of sprouty in this location; this is upregulated in many tissues by EGFR signalling (Campbell, 2002).
The specification of bract cells in Drosophila legs has been analyzed. Mechanosensory bristles induce bract fate in neighboring epidermal cells, and the RAS/MAPK pathway mediates this induction. Spitz and EGF receptor have been identified as the ligand and the receptor of this signaling; by
ubiquitous expression of constitutively activated forms of components of the pathway it has been found that the acquisition of bract fate is temporally
and spatially restricted. The role of the poxn gene in the inhibition of bract induction in chemosensory bristles has also been studied (del Álamo, 2002).
Drosophila legs are covered by a constant and leg-specific pattern of different types of external sensory organs, mainly mechanosensory (MB) or chemosensory (ChB) bristles. Bristles on the legs can be classified by the presence of bracts. Bracts are small epidermal structures that appear associated to MB in specific places on adult femur, tibia and the tarsal segments of all legs. Bracts appear on the proximal side of the bristles,
and share the same polarity. Bracts are also present in the proximal costa of the wing, showing the same morphology as in the leg (del Álamo, 2002).
Are bristle and bract related by lineage? Sensory organ precursors (SOPs) undergo a specific pattern of cell divisions that give rise to four cells: two epidermal cells, the shaft and socket, and two neural cells, a neuron and a sheath cell. Previous clonal analyses of leg disc have suggested a lack of
lineage relationship between bristles and bracts. These results were confirmed by labelling clones of cells induced in early third instar larvae; the bract cell does not belong to the SOP lineage (del Álamo, 2002).
How is bract fate specified? The results indicate that the acquisition of bract fate is controlled at three levels. One level of control takes place in the receptor cell, where the competence to acquire bract fate is spatially and temporally controlled. Ubiquitous expression of activated Raf provided in short pulses of time indicated that the competence to acquire bract fate is spatially restricted to specific regions of imaginal discs. There is also a temporal restriction to early pupal development, with peak competence between 8-12 hours APF. These results are consistent with there being a temporally and spatially restricted expression of a tissue-specific regulator that gives the receptor cell the competence to activate bract fate (del Álamo, 2002).
Another level of control occurs in the bristle cell that sends the inductive signal. Spi protein requires the functions of rho1 and S genes to be processed into a soluble, activated form. S and spi are ubiquitously expressed, and rho1 is expressed in SOP cells. The phenotype of rho1 mutant cells in clones indicates that rho1 is required for the induction of bract fate. Nevertheless, rho1 is also expressed in bract-less ChBs, and ubiquitous overexpression of S and rho1 results in a mild phenotype of extra bracts in wild-type positions. Together these results suggest that another component, whose expression must be restricted to the SOP of MBs, is required for bract induction (del Álamo, 2002).
Home page: The Interactive Fly © 1997 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Society for Developmental Biology's Web server.